DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Vosoritide
Vosoritide
Classification Decisions Taken by the Harmonized System Committee from the 47Th to 60Th Sessions (2011
February 2021 EPS Pipeline Report
CHMP Agenda of the 19-22 April 2021 Meeting
INN-Nimet 1 1.4.2019 a Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum Abagovomabi Abaloparatide Abaloparatidum Abalopara
Networking Breakfast with ASBMR Leaders, NIH Representatives And
PCORI-HCHSS-High Potential Disruption-May-2021
TAG Mail – 26 August 2021 COVID-19 RESOURCES & ARTICLES of INTEREST Please Click This Link for the Cumulative Listing of COVID-19 Resources in Past TAG Mails
Advantages and Disadvantages of Different Treatment Methods in Achondroplasia: a Review
Stembook 2018.Pdf
Ulipristal Acetate
(INN) for Biological and Biotechnological Substances
OCTOBER 2019 Mrx Pipeline a View Into Upcoming Specialty and Traditional Drugs TABLE of CONTENTS
Horizon Scanning Status Report June 2020 Prepared For: Patient-Centered Outcomes Research Institute 1828 L St., NW, Suite 900 Washington, DC 20036
Rxoutlook® 3Rd Quarter 2020
Support for a New Therapeutic Approach of Using a Low-Dose FGFR Tyrosine Kinase Inhibitor (Infigratinib) for Achondroplasia
Bildiri Kitabi Xxii
Voxzogo, INN-Vosoritide
(CHMP) Agenda for the Meeting on 21-24 June 2021
Top View
Rxoutlook® 3Rd Quarter 2021
Pipeline Report August 2021
A View Into Upcoming Specialty & Traditional Drugs
Rxoutlook® 2Nd Quarter 2021
2020 Medicines in Development for Children
New Therapeutic Approaches for Achondroplasia Davide Selom Komi Komla-Ebri
Brand Pipeline Forecast 1St Quarter 2020
Flourous Metabolically Stable Peptide Analogs
(INN) for Biological and Biotechnological Substances
Peptide Therapeutics Update
Rxoutlook® 1St Quarter 2021
Bone Abstracts Vol. 7
April 2018 a View Into Upcoming Specialty and Traditional Drugs TABLE of CONTENTS
Safe and Persistent Growth-Promoting Effects of Vosoritide In
Optumrx Brand Pipeline Forecast
Specialty Pipeline MONTHLY UPDATE
Publication Agenda CHMP 07-10 December 2020
Design, Synthesis and Biophysical Evaluation of Peptides Targeting Pharmacologically Relevant Proteins